Heat Shock Proteins and PD-1/PD-L1 as Potential Therapeutic Targets in Myeloproliferative Neoplasms
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Heat Shock Proteins and PD-1/PD-L1 as Potential Therapeutic Targets in Myeloproliferative Neoplasms
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 9, Pages 2592
Publisher
MDPI AG
Online
2020-09-11
DOI
10.3390/cancers12092592
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neutral analogs of the heat shock protein 70 (Hsp70) inhibitor, JG-98
- (2020) Hao Shao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Unleashing the full potential of Hsp90 inhibitors as cancer therapeutics through simultaneous inactivation of Hsp90, Grp94, and TRAP1
- (2020) Hye-Kyung Park et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancer
- (2020) Lipika Goyal et al. INVESTIGATIONAL NEW DRUGS
- Tracking the evolution of circulating exosomal-PD-L1 to monitor melanoma patients
- (2020) Marine Cordonnier et al. Journal of Extracellular Vesicles
- Synthesis of novel dual target inhibitors of PARP and HSP90 and their antitumor activities
- (2020) Shanshan Lin et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Immune checkpoint signaling and cancer immunotherapy
- (2020) Xing He et al. CELL RESEARCH
- Novel HSP90-PI3K Dual Inhibitor Suppresses Melanoma Cell Proliferation by Interfering with HSP90-EGFR Interaction and Downstream Signaling Pathways
- (2020) Qian Zhao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Biogenesis, Biology, and Clinical Significance of Exosomal PD-L1 in Cancer
- (2020) Yanyan Tang et al. Frontiers in Immunology
- Immunotherapy in Myeloproliferative Diseases
- (2020) Lukas M. Braun et al. Cells
- Involvement of Stat3 phosphorylation in mild heat shock-induced thermotolerance
- (2019) Masashi Matozaki et al. EXPERIMENTAL CELL RESEARCH
- Programmed Cell Death Receptor (PD-1) Ligand (PD-L1) expression in Philadelphia chromosome-negative myeloproliferative neoplasms
- (2019) Jen-Chin Wang et al. LEUKEMIA RESEARCH
- B‐cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: influence of ruxolitinib, interferon‐α2, or combination treatment
- (2019) A L Sørensen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Molecular chaperones in the brain endothelial barrier: neurotoxicity or neuroprotection?
- (2019) Dominique Thuringer et al. FASEB JOURNAL
- Novel Therapies in Myeloproliferative Neoplasms (MPN): Beyond JAK Inhibitors
- (2019) Minas P. Economides et al. Current Hematologic Malignancy Reports
- Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer
- (2019) Dong Ha Kim et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Roles of Extracellular HSPs as Biomarkers in Immune Surveillance and Immune Evasion
- (2019) Eman A. Taha et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effect of the Hsp90 Inhibitor KW-2478 on HepG2 Cells
- (2019) Xiaomin Chang et al. Anti-Cancer Agents in Medicinal Chemistry
- Discovery of 2-((4-resorcinolyl)-5-aryl-1,2,3-triazol-1-yl)acetates as potent Hsp90 inhibitors with selectivity over TRAP1
- (2019) Sejin Jung et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Exosomal HSP70 for Monitoring of Frontotemporal Dementia and Alzheimer’s Disease: Clinical and FDG-PET Correlation
- (2019) Gäetan Chanteloup et al. JOURNAL OF ALZHEIMERS DISEASE
- The role of exosomal PD-L1 in tumor progression and immunotherapy
- (2019) Feiting Xie et al. Molecular Cancer
- Novel Hsp90 Inhibitor C086 Potently Inhibits Non-Small Cell Lung Cancer Cells As A Single Agent Or In Combination With Gefitinib
- (2019) Liman Wang et al. Cancer Management and Research
- AT-533, a novel Hsp90 inhibitor, inhibits breast cancer growth and HIF-1α/VEGF/VEGFR-2-mediated angiogenesis in vitro and in vivo
- (2019) Peng-Chao Zhang et al. BIOCHEMICAL PHARMACOLOGY
- Identification of vibsanin A analog as a novel HSP90 inhibitor
- (2019) Kazuki Miura et al. BIOORGANIC & MEDICINAL CHEMISTRY
- TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naïve and imatinib-resistant gastrointestinal stromal tumours
- (2019) Yurina Saito et al. BRITISH JOURNAL OF CANCER
- Chaperoning STAT3/5 by Heat Shock Proteins: Interest of Their Targeting in Cancer Therapy
- (2019) Gaëtan Jego et al. Cancers
- BJ-B11, an Hsp90 Inhibitor, Constrains the Proliferation and Invasion of Breast Cancer Cells
- (2019) Kaisheng Liu et al. Frontiers in Oncology
- Dual Targeting of Oncogenic Activation and Inflammatory Signaling Increases Therapeutic Efficacy in Myeloproliferative Neoplasms
- (2018) Maria Kleppe et al. CANCER CELL
- Clinical Development of PD-1 Blockade in Hematologic Malignancies
- (2018) Matthew J. Pianko et al. CANCER JOURNAL
- Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy
- (2018) Minan Wang et al. FASEB JOURNAL
- HSP-enriched properties of extracellular vesicles involve survival of metastatic oral cancer cells
- (2018) Kisho Ono et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Exploration of Benzothiazole Rhodacyanines as Allosteric Inhibitors of Protein–Protein Interactions with Heat Shock Protein 70 (Hsp70)
- (2018) Hao Shao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Oncogenic JAK2 V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms
- (2018) Alessandro Prestipino et al. Science Translational Medicine
- HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis
- (2018) Margaux Sevin et al. Nature Communications
- Spontaneous T-cell responses against the immune check point programmed-death-ligand 1 (PD-L1) in patients with chronic myeloproliferative neoplasms correlate with disease stage and clinical response
- (2018) Morten Orebo Holmström et al. OncoImmunology
- The HSP90 Family: Structure, Regulation, Function, and Implications in Health and Disease
- (2018) Abdullah Hoter et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
- (2018) Gang Chen et al. NATURE
- Perspectives on interferon-alpha in the treatment of Polycythemia vera and related Myeloproliferative neoplasms: minimal residual disease and cure?
- (2018) Hans Carl Hasselbalch et al. Seminars in Immunopathology
- The 2018 Nobel Prize in medicine goes to cancer immunotherapy
- (2018) Zong Sheng Guo BMC CANCER
- The Nobel Prize for Medicine awarded for cancer therapy by inhibition of negative immune regulation
- (2018) Peter Hokland et al. BRITISH JOURNAL OF HAEMATOLOGY
- Human bone marrow contains high levels of extracellular vesicles with a tissue-specific subtype distribution
- (2018) Andreas Rank et al. PLoS One
- Immunotherapy of cancers comes of age
- (2017) Hila Yousefi et al. Expert Review of Clinical Immunology
- Hsp90 inhibition disrupts JAK-STAT signaling and leads to reductions in splenomegaly in patients with myeloproliferative neoplasms
- (2017) Gabriela S. Hobbs et al. HAEMATOLOGICA
- Mechanisms of Resistance to JAK2 Inhibitors in Myeloproliferative Neoplasms
- (2017) Sara C. Meyer HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Extracellular Vesicles in Hematological Malignancies: From Biology to Therapy
- (2017) Antonella Caivano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- First-in-human study of the epichaperome inhibitor PU-H71: clinical results and metabolic profile
- (2017) Giovanna Speranza et al. INVESTIGATIONAL NEW DRUGS
- Checkpoint inhibitors in hematological malignancies
- (2017) Chi Young Ok et al. Journal of Hematology & Oncology
- The small heat shock protein Hsp27: Present understanding and future prospects
- (2017) Manish Kumar Singh et al. JOURNAL OF THERMAL BIOLOGY
- Heat shock protein 27 (HSP27/HSPB1) expression is increased in patients with primary and secondary myelofibrosis and may be affecting their survival
- (2017) Marko Lucijanic et al. LEUKEMIA & LYMPHOMA
- Extracellular cell stress (heat shock) proteins—immune responses and disease: an overview
- (2017) A. Graham Pockley et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Hsp90 inhibition disrupts JAK-STAT signaling and leads to reductions in splenomegaly in patients with myeloproliferative neoplasms
- (2017) Gabriela S. Hobbs et al. HAEMATOLOGICA
- Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade
- (2017) Jun Zhou et al. Cancer Immunology Research
- Clinical, Prognostic and Therapeutic Significance of Heat Shock Proteins in Cancer
- (2017) Jasleen Saini et al. CURRENT DRUG TARGETS
- Emerging treatments for classical myeloproliferative neoplasms
- (2016) Alessandro M. Vannucchi et al. BLOOD
- The human HSP70 family of chaperones: where do we stand?
- (2016) Jürgen Radons CELL STRESS & CHAPERONES
- Therapeutic and diagnostic applications of extracellular vesicles
- (2016) Stephan Stremersch et al. JOURNAL OF CONTROLLED RELEASE
- Genetic and Epigenetic Regulation of PD-1 Expression
- (2016) Alexander P. R. Bally et al. JOURNAL OF IMMUNOLOGY
- The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms
- (2016) M O Holmström et al. LEUKEMIA
- Myeloid-derived suppressor cells in patients with myeloproliferative neoplasm
- (2016) Jen Chin Wang et al. LEUKEMIA RESEARCH
- Extracellular Release and Signaling by Heat Shock Protein 27: Role in Modifying Vascular Inflammation
- (2016) Zarah Batulan et al. Frontiers in Immunology
- The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation
- (2016) Kankana Bardhan et al. Frontiers in Immunology
- Extracellular HSP110 skews macrophage polarization in colorectal cancer
- (2016) Kevin Berthenet et al. OncoImmunology
- Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
- (2015) Lieping Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer
- (2015) Jessica Gobbo et al. JNCI-Journal of the National Cancer Institute
- Interferon-alpha for the therapy of myeloproliferative neoplasms: targeting the malignant clone
- (2015) J-J Kiladjian et al. LEUKEMIA
- HSP90 and HSP70: Implication in Inflammation Processes and Therapeutic Approaches for Myeloproliferative Neoplasms
- (2015) Margaux Sevin et al. MEDIATORS OF INFLAMMATION
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Do not stress, just differentiate: role of stress proteins in hematopoiesis
- (2015) C Boudesco et al. Cell Death & Disease
- Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression
- (2015) Laura Pinton et al. Oncotarget
- Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer
- (2015) Jessica Gobbo et al. JNCI-Journal of the National Cancer Institute
- Improved targeting of JAK2 leads to increased therapeutic efficacy in myeloproliferative neoplasms
- (2014) Neha Bhagwat et al. BLOOD
- Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis
- (2014) R. Rampal et al. BLOOD
- Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions
- (2014) Komal Jhaveri et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- HSP70 sequestration by free α-globin promotes ineffective erythropoiesis in β-thalassaemia
- (2014) Jean-Benoît Arlet et al. NATURE
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms
- (2014) Raajit Rampal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm
- (2013) Santiago Barrio et al. BRITISH JOURNAL OF HAEMATOLOGY
- Co-targeting the PI3K/mTOR and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms
- (2013) Niccolò Bartalucci et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Proteomic analysis reveals heat shock protein 70 has a key role in polycythemia Vera
- (2013) Miguel Gallardo et al. Molecular Cancer
- Dual PI3K/AKT/mTOR Inhibitor BEZ235 Synergistically Enhances the Activity of JAK2 Inhibitor against Cultured and Primary Human Myeloproliferative Neoplasm Cells
- (2013) W. Fiskus et al. MOLECULAR CANCER THERAPEUTICS
- Extracellular Heat Shock Proteins
- (2013) Antonio De Maio et al. SHOCK
- Analogues of the Allosteric Heat Shock Protein 70 (Hsp70) Inhibitor, MKT-077, As Anti-Cancer Agents
- (2013) Xiaokai Li et al. ACS Medicinal Chemistry Letters
- Inhibition of HSP70: A challenging anti-cancer strategy
- (2012) Anastasia R. Goloudina et al. CANCER LETTERS
- Heat shock proteins in hematopoietic malignancies
- (2012) Hajare Mjahed et al. EXPERIMENTAL CELL RESEARCH
- Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition
- (2012) Oliver Weigert et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selective Effects of PD-1 on Akt and Ras Pathways Regulate Molecular Components of the Cell Cycle and Inhibit T Cell Proliferation
- (2012) N. Patsoukis et al. Science Signaling
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
- (2012) J. M. Taube et al. Science Translational Medicine
- JAK2 the future: therapeutic strategies for JAK-dependent malignancies
- (2012) Lindsay M. LaFave et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers
- (2011) Komal Jhaveri et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Defective nuclear localization of Hsp70 is associated with dyserythropoiesis and GATA-1 cleavage in myelodysplastic syndromes
- (2011) E. Frisan et al. BLOOD
- Peptides and Aptamers Targeting HSP70: A Novel Approach for Anticancer Chemotherapy
- (2011) Anne-Laure Rérole et al. CANCER RESEARCH
- Heat Shock Protein 90 Inhibitor Is Synergistic with JAK2 Inhibitor and Overcomes Resistance to JAK2-TKI in Human Myeloproliferative Neoplasm Cells
- (2011) W. Fiskus et al. CLINICAL CANCER RESEARCH
- Multifaceted Intervention by the Hsp90 Inhibitor Ganetespib (STA-9090) in Cancer Cells with Activated JAK/STAT Signaling
- (2011) David A. Proia et al. PLoS One
- HSP27 controls GATA-1 protein level during erythroid cell differentiation
- (2010) A. de Thonel et al. BLOOD
- Targeting heat shock proteins in cancer
- (2010) Gaëtan Jego et al. CANCER LETTERS
- HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humans
- (2010) Sachie Marubayashi et al. JOURNAL OF CLINICAL INVESTIGATION
- Activity of IPI-504, a Novel Heat-Shock Protein 90 Inhibitor, in Patients With Molecularly Defined Non–Small-Cell Lung Cancer
- (2010) Lecia V. Sequist et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia
- (2010) J E Lancet et al. LEUKEMIA
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model
- (2009) L. Zhang et al. BLOOD
- Dual Control of Antitumor CD8 T Cells through the Programmed Death-1/Programmed Death-Ligand 1 Pathway and Immunosuppressive CD4 T Cells: Regulation and Counterregulation
- (2009) A. J. Currie et al. JOURNAL OF IMMUNOLOGY
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Heat shock proteins: essential proteins for apoptosis regulation
- (2008) D. Lanneau et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal
- (2008) A M Vannucchi et al. LEUKEMIA
- Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)
- (2008) M. Marzec et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now